BRIEF-Edgewise Therapeutics Q1 Operating Expenses USD 54.115 Million
Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. EWTX | 0.00 |
May 07 (Reuters) - Edgewise Therapeutics Q1 net income USD -49.013 million.
- Q1 basic EPS USD -0.46
- Q1 operating income USD -54.115 million
